Shopping Cart
- Remove All
Your shopping cart is currently empty
EC0489 is a small molecule-drug conjugate (SMDC) that combines folic acid and desacetyl vinblastine hydrazide, serving as a high-affinity ligand for the folate receptor (FR) in refractory or metastatic tumors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | Backorder |
| Description | EC0489 is a small molecule-drug conjugate (SMDC) that combines folic acid and desacetyl vinblastine hydrazide, serving as a high-affinity ligand for the folate receptor (FR) in refractory or metastatic tumors. |
| In vitro | FR-positive KB cells are highly sensitive to EC0489 with an IC50 of 5 nM.The affinity of EC0489 toward the folate receptor (FR) is approximately half of that of folic acid (relative affinity 0.50). |
| In vivo | EC0489, administered at doses of 2, 3, and 4 μmol/kg, exhibits dose-dependent antitumor activity in mouse KB tumor models. Furthermore, EC0489 demonstrates a favorable toxicology profile in rats. |
| Molecular Weight | 2550.7 |
| Formula | C111H156N22O43S2 |
| Cas No. | 1096702-14-5 |
| Relative Density. | 1.66 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.